Jörgen Carlsson
About
In The Last Decade
Jörgen Carlsson
126 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 125
- Radiology, Nuclear Medicine and Imaging 2.9k
- Oncology 1.6k
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 711
- Biomedical Engineering 516
Countries citing papers authored by Jörgen Carlsson
This map shows the geographic impact of Jörgen Carlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörgen Carlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörgen Carlsson more than expected).
Fields of papers citing papers by Jörgen Carlsson
This network shows the impact of papers produced by Jörgen Carlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörgen Carlsson. The network helps show where Jörgen Carlsson may publish in the future.
Co-authorship network of co-authors of Jörgen Carlsson
This figure shows the co-authorship network connecting the top 25 collaborators of Jörgen Carlsson. A scholar is included among the top collaborators of Jörgen Carlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörgen Carlsson. Jörgen Carlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | GMP compliant preparation of a (68)Gallium-labeled Affibody analogue for breast cancer patient examination : first-in-man | 3 |
| 3 | Measuring HER2-expression in metastatic breast cancer using 68Ga-ABY025 PET/CT | 3 |
| 4 | 41 | |
| 5 | 55 | |
| 6 | Targeted Radionuclide Tumor Therapy : Biological Aspects | 20 |
| 7 | Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. | 73 |
| 8 | 78 | |
| 9 | 8 | |
| 10 | 47 | |
| 11 | 20 | |
| 12 | 15 | |
| 13 | 20 | |
| 14 | 15 | |
| 15 | 20 | |
| 16 | Cellular processing of iodinated and astatinated trastuzumab in cultured SK-BR-3 breast cancer cells | 1 |
| 17 | The use of benzyl isothiocyanate derivative of closo-dodecaborate dianion for indirect radioiodination and radiobromination of monoclonal antibodies | 1 |
| 18 | 1 | |
| 19 | 41 | |
| 20 | Penetration and Binding of EGF-Dextran Conjugates in Cultured-Cell Spheroids | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.